| Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality D Costa, B Simbrunner, M Jachs, L Hartl, D Bauer, R Paternostro, ... Journal of Hepatology 74 (4), 819-828, 2021 | 160 | 2021 |
| Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes M Jachs, L Hartl, D Schaufler, C Desbalmes, B Simbrunner, E Eigenbauer, ... Gut 70 (9), 1758-1767, 2021 | 73 | 2021 |
| Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis BS Hofer, B Simbrunner, L Hartl, M Jachs, DJM Bauer, L Balcar, ... Clinical Gastroenterology and Hepatology 21 (9), 2308-2317. e7, 2023 | 65 | 2023 |
| Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease L Hartl, K Haslinger, M Angerer, G Semmler, M Schneeweiss‐Gleixner, ... Hepatology 76 (6), 1563-1575, 2022 | 63 | 2022 |
| Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study M Jachs, C Schwarz, M Panzer, T Binter, SW Aberle, L Hartl, K Dax, ... Alimentary pharmacology & therapeutics 56 (1), 144-154, 2022 | 63 | 2022 |
| Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, L Balcar, B Hofer, ... Clinical Gastroenterology and Hepatology 21 (9), 2318-2326. e7, 2023 | 54 | 2023 |
| Safety of direct oral anticoagulants in patients with advanced liver disease G Semmler, K Pomej, DJM Bauer, L Balcar, B Simbrunner, T Binter, ... Liver International 41 (9), 2159-2170, 2021 | 51 | 2021 |
| Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease G Semmler, Z Yang, L Fritz, F Köck, BS Hofer, L Balcar, L Hartl, M Jachs, ... Gastroenterology 165 (4), 1041-1052, 2023 | 49 | 2023 |
| The sequential application of Baveno VII criteria and VITRO score improves diagnosis of clinically significant portal hypertension M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, B Scheiner, ... Clinical Gastroenterology and Hepatology 21 (7), 1854-1863. e10, 2023 | 47 | 2023 |
| Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event L Balcar, M Tonon, G Semmler, V Calvino, L Hartl, S Incicco, M Jachs, ... JHEP Reports 4 (8), 100513, 2022 | 47 | 2022 |
| Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, B Scheiner, ... Clinical Gastroenterology and Hepatology 20 (6), 1362-1373. e6, 2022 | 47 | 2022 |
| Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD B Scheiner, L Balcar, RJ Nussbaumer, J Weinzierl, R Paternostro, ... Journal of hepatology 76 (5), 1090-1099, 2022 | 44 | 2022 |
| Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies P Königshofer, BS Hofer, K Brusilovskaya, B Simbrunner, O Petrenko, ... Hepatology 75 (3), 610-622, 2022 | 34 | 2022 |
| Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure L Balcar, G Semmler, K Pomej, B Simbrunner, D Bauer, L Hartl, M Jachs, ... UEG Journal 9 (4), 427-437, 2021 | 30 | 2021 |
| Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis BS Hofer, B Simbrunner, L Hartl, M Jachs, L Balcar, R Paternostro, ... Liver International 43 (10), 2220-2231, 2023 | 29 | 2023 |
| Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial D Mrak, D Sieghart, E Simader, S Tobudic, H Radner, P Mandl, L Göschl, ... Nature Communications 13 (1), 5362, 2022 | 28 | 2022 |
| Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis M Jachs, T Binter, C Schmidbauer, L Hartl, M Strasser, H Laferl, ... UEG Journal 9 (10), 1119-1127, 2021 | 28 | 2021 |
| Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder K Lampichler, G Semmler, K Wöran, B Simbrunner, M Jachs, L Hartl, ... European Radiology 33 (2), 1422-1432, 2023 | 25 | 2023 |
| Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease L Balcar, J Krawanja, B Scheiner, R Paternostro, B Simbrunner, ... JHEP Reports 5 (4), 100682, 2023 | 24 | 2023 |
| Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient M Jachs, L Hartl, B Simbrunner, G Semmler, L Balcar, BS Hofer, ... Journal of hepatology 80 (5), 744-752, 2024 | 23 | 2024 |
